港股異動丨創科實業再度升超4% 績後獲多家大行唱好
創科實業(0669.HK)再度升超4%,績後實現2連升。現報98.9港元,總市值1812億港元。公司截至今年6月底止中期營業額73.12億美元,同比升6.29%;盈利5.5億美元,同比增長15.67%。該公司績後獲多家大行唱好。大摩報吿指,創科實業今年上半年業績獲更佳銷售與毛利率支持,重申對其目標價116港元,評級“增持”;摩根大通上調公司目標價至135港元;維持“增持”評級;瑞銀維持公司“買入”評級,料下半年毛利率將持續擴充;里昂維持公司“跑贏大市”評級,對擴大市場佔有率有信心。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.